Drug Shortage Report for VEPESID

Last updated on 2018-12-20 History
Report ID 49573
Drug Identification Number 00616192
Brand name VEPESID
Common or Proper name Etoposide
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) ETOPOSIDE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 20
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-12-18
Actual start date 2018-12-20
Estimated end date 2018-12-28
Actual end date 2018-12-19
Shortage status Avoided shortage
Updated date 2018-12-20
Company comments We will be allocating orders until the new supply is available.
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-05-16 English Compare
v2 2018-05-16 French Compare
v3 2018-06-14 English Compare
v4 2018-06-14 French Compare
v5 2018-06-27 English Compare
v6 2018-06-27 French Compare
v7 2018-06-27 English Compare
v8 2018-06-27 French Compare
v9 2018-07-23 English Compare
v10 2018-07-23 French Compare
v11 2018-09-29 English Compare
v12 2018-09-29 English Compare
v13 2018-09-29 French Compare
v14 2018-10-16 English Compare
v15 2018-10-16 English Compare
v16 2018-10-16 French Compare
v17 2018-11-17 English Compare
v18 2018-11-19 English Compare
v19 2018-11-19 French Compare
v20 2018-12-01 English Compare

Showing 1 to 20 of 34